References
- Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics 2000. CA Cancer J Clin 2000; 50: 7–33
- Srivastava S, Verma M, Henson DE. Biomarkers for early detection of colon cancer. Clin Cancer Res 2001; 7: 1118–26
- Agency for Health Care Policy (AHCPR) Research activity. 1997;200:15–8.
- Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. N Natl Cancer Inst 1993; 85: 1311–8
- Ahlquist, DA. Occult gastrointestinal bleeding. In: Yamada T, editor. Textbook of gastroenterology. New York: J.B. Lippincott and Co; 1995. pp 6669–721.
- Macrae FA, St John JB, Caligiore P, Taylor LS, Legge JW. Optimal dietary conditions for Hemocult testing. Gastroenterology 1982; 82: 899–903
- Pasche B, Mulcahy M, Benson AB. Molecular markers in prognosis of colorectal cancer and prediction of response to treatment. Best practice and research. Clin Gastroenterol 2002; 16: 331–45
- Lowenfels AB. Fecal occult blood testing as a screening procedure for colorectal cancer. Ann Oncol 2002; 13: 40–3
- Kronborg O. Colon polyps and cancer. Endoscopy 2002; 34: 69–72
- Iyengar V, Albaugh G, Lohani A, Nair PP. Human stools as a source of viable colonic epithelial cells. FASEB J 1992; 5: 2856–9
- Albaugh G, Iyengar V, Lohani A, Malayeri M, Bala S, Nair PP. Isolation of exfoliated colonic epithelial cells, a novel non-invasive approach to the study of cellular markers. Int J Cancer 1992; 52: 347–50
- Nair PP, Lagerholm S, Dutta S, Shami S, Davis K, Shuzhen M, et al. Coprocytobiology: on the nature of cellular elements from stools in the pathophysiology of colonic disease. J Clin Gastroenterol 2003; 36 Suppl 1: S84–S93
- Desilets DJ, Davis KE, Nair PP, Salata KF, Maydonovitch BS, Howard RS, et al. Lectin binding to human colonocytes is predictive of colonic neoplasia. Am J Gastroenterol 1999; 94: 744–50
- Malayeri M, Albaugh G, Davis R, Bhathena S, Nair PP. Exfoliated human colonic epithelial cells: insulin binding and molecular cloning of the insulin receptor. Med Sci Res 1997; 25: 801–3
- Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Sehoetz DJ, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002; 346: 311–20
- Galandiuk S, Miseljic S, Yang AR, Early M, McCoy MD, Witliff JL. Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic disease. Arch Surg 1993; 128: 637–42
- Ishida H, Sadahiro S, Suzuki T, Ishikawa K, Tajima T, Makuuchi H. c-erbB-2 protein expression and clinicopathologic features in colorectal cancer. Oncol Reports 2000; 7: 1229–33
- Vizoso F, Villar C, Rodriguez JC, Raigoso P, Garcia-Mun JL, Allende MT. c-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance. I. J Surg Invest 2000; 1: 483–93
- Slikowski M, du Bois R. HER-2/neu overexpression in colonic malignancies. Gastroenterology 2002; 122: 248–9
- Maurer C, Friess H, Kretschmann B. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol 1998; 29: 771–7
- Shu M, Liu S, Yu P. Expression and significance of p53, c-erbb2, CEA proteins in colorectal adenoma and carcinoma. Hunan Yi Ke Da Xue Xue Bao 1998; 23: 129–31
- Ross JS, McKenna BJ. The HER2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 2001; 19: 554–68
- Mckay J, Loane J, Ross V, Ameyaw MM, Murray GI, Cassidy J, et al. c-erbB-2 is not a major factor in the development of colorectal cancer. Br J Cancer 2002; 86: 568–73
- Kaye M. Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer 2001; 34: S43–S6
- Schuldiner O, Benvenisty N. A DNA microarray screen for genes involved in c-myc and N-myc oncogenesis in human tumors. Oncogene 2001; 20: 4984–94
- Lutz W, Leon J, Eilers M. Contributions of Myc to tumorigenesis. Biochim Biophys Acta 2002; 1602: 61–71
- Hann S, Eisenman R. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol 1984; 4: 2486–97
- Greco C, Alvino S, Buglioni S, Assisi D, Capenta R, Grassi A, et al. Activation of c-myc and c-myb proto-oncogenes is associated with decreased apoptosis in tumor colon progression. Anticancer Res 2001; 21: 3185–92